Cryptogenic Cirrhosis and Hepatopulmonary Syndrome in a Boy with Hepatic Hemangioma in Botswana: A Case Report and Review of the Literature

Table 1

Laboratory results.

Age	8 m	4 y
FBC^a
WBC (5−10 × 10^3/mL)	12	8
Neutrophils (40−60%)	68	42
Lymphocytes (20−40%)	31	28
Hb (11.5−14 g/dL)	10	17.1
MCV (75−90 fL)	88	67.5
Platelets (145−450 × 10^3/mL)	470	100
LFTs^b
Total bilirubin (<17.1 µmol/L)	0.8	0.53
Total protein (63−80 mg/dL)	76.3	71.7
Albumin 35−55 mg/dL	34.5	33
ALP (50−160 IU/L)	257.8	262
ALT (0−30 IU/L)	78	75.4
AST (0−40 IU/L)	86.3	84
GGT (0−30 IU/L)	63.6	69
LDH (140−280 IU/L)	220	262
U and E^c
Na (135−145 mmol/L)	142	—
K (3.5−5.5 mmol/L)	3.8	—
Cl (98−106 mmol/L)	101	—
Urea (7–14 mmol/L)	22	—
Creatinine (88−176 µmol/L)	83.7	—
TFTs^d
FT4 (3.5−6.5 µg/dL)	3.78	—
T3 (11.5−22.7 ng/dL)	20.13	—
TSH (0.35−5.5 µU/mL)	4.81	—
Coagulation
aPTT (30−45 s)	35	30.6
INR (0.8−1.2)	0.97	1.13
Serum serology studies
Hepatitis A and B viruses	Negative	Negative
Autoimmune screen
ANAs	—	Negative
Serum immunoglobulins	—	Normal

^aFull blood count; ^bliver function tests; ^curea and electrolytes; ^dthyroid function tests.